Log In
BCIQ
Print this Print this
 

Apocept (APG101)

  Manage Alerts
Collapse Summary General Information
Company Apogenix GmbH
DescriptionSoluble fusion protein combining the extracellular domain of CD95 and the Fc portion of IgG
Molecular Target CD95 ligand
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/28/2015

Undisclosed

Undisclosed

Undisclosed

07/15/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today